Keyphrases
Alanine Aminotransferase
12%
Apolipoprotein B (Apo B)
25%
Aspartate Aminotransferase
12%
Bedtime
12%
Bile Acid Sequestrants
12%
Cholesterol
25%
Extended Release
12%
Extended-release Niacin
100%
Female Adults
12%
Hepatic Effects
12%
High-density Lipoprotein Cholesterol (HDL-C)
37%
Hydroxymethylglutaryl-CoA Reductases
12%
Hypercholesterolemia
100%
Intolerance
12%
Lipoproteins
37%
Long-term Efficacy
12%
Long-term Safety
12%
Long-term Treatment
12%
Low-density Lipoprotein
12%
Low-density Lipoprotein Cholesterol (LDL-C)
25%
Male Adults
12%
Niacin
12%
Niaspan
100%
Once-nightly
100%
Overall Rate
12%
Patients Included
12%
Randomized Trial
12%
Safety Data
12%
Statin Therapy
12%
Statins
25%
Transaminase Elevations
12%
Triglycerides
37%
Pharmacology, Toxicology and Pharmaceutical Science
Alanine Aminotransferase
10%
Apolipoprotein B
20%
Aspartate Aminotransferase
10%
Bile Acid Sequestrant
10%
High Density Lipoprotein Cholesterol
30%
Hydroxymethylglutaryl Coenzyme A Reductase
10%
Hypercholesterolemia
100%
Hypertransaminasemia
10%
Lipoprotein A
30%
Low Density Lipoprotein
10%
Low Density Lipoprotein Cholesterol
20%
Nicotinic Acid
100%
Statin (Protein)
30%
Triacylglycerol
30%